In a patient with previously well-controlled hypothyroidism who is now symptomatic, should I recheck serum thyroid‑stimulating hormone (TSH) now, and if so how soon, or should I increase the levothyroxine dose?

Recheck TSH First—Do Not Empirically Increase Levothyroxine

In a patient with previously well-controlled hypothyroidism who becomes symptomatic, you should recheck serum TSH within 4-8 weeks rather than empirically increasing the levothyroxine dose. This approach allows you to confirm whether the symptoms are truly due to inadequate thyroid replacement or represent another underlying condition entirely.

Why Check TSH Before Adjusting Dose

The most critical step is determining whether hypothyroidism is actually causing the symptoms. Dose adjustments should be guided by serum TSH determinations 4-8 weeks following any dosage change or when clinical status changes 1. The FDA labeling reinforces this, stating that in adults with primary hypothyroidism, you should monitor serum TSH levels after an interval of 6 to 8 weeks after any change in dosage, and evaluate clinical and biochemical response whenever there is a change in the patient's clinical status 2.

Common Pitfalls to Avoid

Before assuming the patient needs more levothyroxine, systematically evaluate these factors that can cause apparent treatment failure:

• Non-compliance is the most common cause of elevated TSH in patients on high-dose levothyroxine (>200 mcg/d) 1, 3. Directly assess medication adherence.

• Absorption issues: Ask about timing of levothyroxine administration. It should be taken 30-60 minutes before breakfast on an empty stomach 1. Concurrent medications or supplements (calcium, iron, proton pump inhibitors, bile acid sequestrants) can interfere with absorption 1.

• Incidental TSH fluctuations: Research shows that in properly treated hypothyroid patients with normal TSH values, an incidentally mildly elevated TSH (4.5-8.0 mIU/L) often normalizes spontaneously within 6 months without dose adjustment 4. Physicians should refrain from promptly increasing the LT4 dose unless TSH values are persistently elevated or progressing.

• Alternative diagnoses: Nearly one-third of individuals started on thyroid hormone are actually euthyroid at initiation 5. Nonspecific symptoms (fatigue, weight gain, depression) have poor positive predictive value for hypothyroidism when TSH is normal. The true underlying cause may be unrelated to thyroid function.

Algorithmic Approach

1. Order TSH now (can add free T4 if concerned about central hypothyroidism or compliance issues)

2. While awaiting results, review:

   • Medication adherence patterns
   • Timing of levothyroxine administration relative to meals
   • New medications or supplements that interfere with absorption
   • Recent weight changes, pregnancy status, or age-related factors (elderly patients may require 20-25% less levothyroxine) 1

3. Interpret TSH results at 4-8 weeks:

   • If TSH is elevated: Adjust levothyroxine dose by 12.5-25 mcg increments 1, 2
   • If TSH is normal: Pursue alternative diagnoses for symptoms; do not increase dose
   • If mildly elevated (4.5-8.0 mIU/L) and patient previously stable: Consider rechecking in another 4-8 weeks before adjusting, as this may normalize spontaneously 4

4. Recheck TSH 4-8 weeks after any dose adjustment until stable 1, 2

Timing Considerations

The 4-8 week interval is critical because TSH levels may decline within a month with higher doses (50-75 mcg), but smaller dose adjustments may require 8 weeks or longer before TSH levels plateau 1. Testing too early leads to inappropriate dose escalation.

Special Circumstances

• If adrenal insufficiency is suspected: Rule this out before adjusting levothyroxine, as thyroid hormone can precipitate adrenal crisis 1
• If patient is elderly or has coronary disease: Be particularly cautious about dose increases; symptoms may not be thyroid-related, and overtreatment increases cardiovascular risks 1
• If patient is on high doses (>200 mcg/d): This strongly suggests non-compliance or malabsorption rather than need for further increase 1

The evidence consistently shows that empirically increasing levothyroxine without biochemical confirmation leads to overtreatment in approximately 20% of patients, with significant cardiovascular and skeletal consequences 1. Always let the TSH guide your dosing decisions, not symptoms alone.